Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer
Crossref DOI link: https://doi.org/10.1007/s00345-016-1853-z
Published Online: 2016-05-18
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Singla, Nirmish
Haddad, Ahmed Q.
Passoni, Niccolo M.
Meissner, Matthew
Lotan, Yair
Text and Data Mining valid from 2016-05-18